GX Pharma
A leader in innovative drug research and clinical solutions, recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years.
A leader in innovative drug research and clinical solutions, recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years.
GX Pharma, a leader in innovative drug research and clinical solutions, has been recognized among China's top outsourcing firms in pharmaceuticals for three consecutive years. Founded in 2008, the company specializes in pioneering drug research and development, as well as clinical trials. GX Pharma offers comprehensive clinical research services and provides complete registration and declaration solutions for innovative drugs and biological products. Since 2018, GX Pharma has consistently been acknowledged as one of the "Top 20 Outsourcing Companies in China's Pharmaceutical Industry" for three consecutive years. The company's most recent investment was a CNY90.00M Series B investment on 13 December 2022, with participation from In Capital, Zhongguancun Bank, and Shenzhen Qianhai Beizeng Asset Management. GX Pharma's focus on cutting-edge drug research, strong track record of recognition, and recent significant investment make it a compelling player in the biotechnology industry, with promising growth potential and a solid foundation for further expansion and innovation.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | CNY90.00M | 3 |
|
13 Dec 2022 |
| Series B | CNY100.00M | 2 |
|
27 Oct 2021 |
| Series A | CNY100.00M | 1 |
|
24 Sep 2020 |
No recent news or press coverage available for GX Pharma.
We care about your data, and we'd love to use cookies make your experience better.
